from health spend data to improved financial & clinical outcomes

©ALL RIGHTS RESERVED - Confidential 1

Scott PrydeBravoSolution UK

From Data Aggregation to Improved Financial & Clinical Outcomes... What is possible now?


Alignment, Governance & Information

# Field Safety Notices


Reimbursement, Cost & Revenue Leakage


Underpinning Savings Initiatives


Hospital Spend Data Quality

NB One exception: Typically where there is a significant peak in Building and Construction works, the data quality drops to very low in that category as data on major works is almost always held on a separate construction system


Misleading Data


MPN Overlap & Variety by Trust

# of Organisations

% O

verla

p

% Common SKU by No. Of Trusts


Catalogue Ref: 157004070 - C-STEM AMT SIZE1 STD OFFSET - EACHeClass: Medical Prosthesis – Joint Replacement HipsBenchmark: Medical Devices - Orthopaedic – Primary – Hip - Stem – Uncemented

What’s in a number ?

[C1 (8004) 12345699999 157004070 (19) 9999999 (21) 99999999

(Asset Identifier)(Organisation ID )(ProductCode)(Lot No.) XX(Serial No.)XXX

What’s not ?


Aggregation & Classification


Price Benchmarking


Evidence Tracking


Other Medical category examples ...

Trauma Nail Demand Volatility / Time


Opportunity Analysis & Guidance

Spend £557,160

% Savings Value Complexity

A 57% £320,000 10

Aggressive brand repositioning to lower price high evidence cemented products e.g. Lubinus SPII, National Regional collaborative bulk commitment and surgeon led negotiation, Manage Consignments directly

B 52% £291,000 9

Alignment with National lowest price clinical policy and brand usage, Significant shift from uncemented to cemented products. Cllaborative, surgeon led negotiation and bulk commitment to maximise leverage

C 27% £150,000 6

Alignment with National average price aligning with technology indicator averages and brand choices. Collaborative, surgeon led negotiation and bulk commitment to maximise leverage

D 17% £96,000 3 Consolidate current brand usage and surgeon led commercial negotiationE 13% £70,000 1 Ceramic on Ceramic - reduce to national average.F -18% -£100,000 0 Uncontroled brand usage & supply base fragmentation


Shared Market Intelligence


Summary

• Investing in data aggregation is essential alongside improving systems & standards

• Data aggregation, analysis & information sharing is possible now

• Improved financial and clinical outcomes will follow

• BUT ..... information is a compass not a silver bullet ... delivery competency will still be required to achieve value

• Co-operate to share market, technology , strategy expertise & knowledge across the system


Executive Briefings

Hospital Benchmarking & Analytics

Understanding GS1 & Data Aggregation

Outcome led Contract Management

MedTech Market Analysis

Inventory, Demand & Utilisation Analytics

Clinical Commissioning Group Spend Analysis

CCG Non-Medical Auctions & Strategies

Scott PrydeBravoSolution UK

from health spend data to improved financial & clinical outcomes

Documents